Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland.
Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions.
Nurr1 reduction influences the onset of chronic EAE in mice.
Core muscle characteristics during walking of patients with multiple sclerosis.
Acute inflammation alters adult hippocampal neurogenesis in a multiple sclerosis mouse model.
Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding.
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.
Vasomotor reactivity comparison in multiple sclerosis patients with white matter lesions and nonmultiple sclerosis subjects with white matter lesions in brain magnetic resonance imaging.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Multiple sclerosis: Hematopoietic stem cell transplantation: hope and hype.
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Correction: Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats.
Synthesis of 1,4-anthracene-9,10-dione derivatives and their regulation of nitric oxide, IL-1β and TNF-α in activated RAW264.7 cells.
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis.
B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
Status migrainosus as an initial presentation of multiple sclerosis.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
Positive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overview.
Natalizumab treatment for multiple sclerosis.
Pages
« first
‹ previous
…
474
475
476
477
478
479
480
481
482
…
next ›
last »